Shionogi
Shionogi supply the best possible medicine to protect the health and wellbeing of the patients they serve.
Launch date
Employees
Market cap
CAD18.8b
Enterprise valuation
CAD13.3b (Public information from Sep 2024)
Share price
JPY6466
Osaka Osaka Prefecture (HQ)
Financials
Estimates*
| EUR | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|
| Revenues | 2.1b | 2.3b | 3.0b | 3.0b | 3.1b | 3.2b | 3.3b |
| % growth | (11 %) | 13 % | 27 % | 2 % | 1 % | 4 % | 3 % |
| EBITDA | 926m | 887m | 1.2b | 1.2b | 1.3b | 1.2b | 1.3b |
| % EBITDA margin | 44 % | 38 % | 39 % | 39 % | 41 % | 39 % | 39 % |
| Profit | 783m | 799m | 1.3b | 1.1b | 1.1b | 1.1b | 1.2b |
| % profit margin | 38 % | 34 % | 43 % | 37 % | 37 % | 35 % | 36 % |
| EV / revenue | 5.1x | 6.0x | 3.4x | 4.2x | 3.2x | 3.0x | 2.6x |
| EV / EBITDA | 11.5x | 16.0x | 8.8x | 10.7x | 7.8x | 7.6x | 6.7x |
Source: Dealroom estimates
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | N/A | IPO | |
| Total Funding | - | ||
Related Content
Recent News about Shionogi
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
ACQUISITION by Virtual Therapeutics May 2024
ACQUISITION by Shionogi Jul 2011
